Does hyperthermic intraoperative chemotherapy lead to improved outcomes in patients with ovarian cancer? A single center cohort study in 111 consecutive patients

BACKGROUND: For recurrent disease or primary therapy of advanced ovarian cancer, cytoreductive surgery (CRS) followed by adjuvant chemotherapy is a therapeutic option. The aim of this study was to evaluate the outcome for patients with epithelial ovarian cancer treated with hyperthermic intraoperati...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Warschkow, Rene, Tarantino, Ignazio, Lange, Jochen, Müller, Sascha A, Schmied, Bruno M, Zünd, Michael, Steffen, Thomas
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2012
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3407737/
https://ncbi.nlm.nih.gov/pubmed/22709648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1754-9493-6-12
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky